173 related articles for article (PubMed ID: 37386550)
1. Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19.
Mazzeo AT; Noto A; Asmundo A; Granata F; Galletta K; Mallamace R; De Gregorio C; Puliatti F; Fazio MC; Germano' A; Musolino C; Ferlazzo G
J Anesth Analg Crit Care; 2021 Nov; 1(1):15. PubMed ID: 37386550
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
[TBL] [Abstract][Full Text] [Related]
3. Case of Suspected SARS-CoV-2 Vaccine-induced Immune Thrombotic Thrombocytopenia: Dilemma for Organ Donation.
Tiwari AM; Zirpe KG; Gurav SK; Bhirud LB; Suryawanshi RS; Kulkarni SS
Indian J Crit Care Med; 2022; 26(4):514-517. PubMed ID: 35656057
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis.
Palaiodimou L; Stefanou MI; Katsanos AH; Aguiar de Sousa D; Coutinho JM; Lagiou P; Michopoulos I; Naska A; Giannopoulos S; Vadikolias K; Voumvourakis KI; Papaevangelou V; Vassilakopoulos TI; Tsiodras S; Tsivgoulis G
Neurology; 2021 Nov; 97(21):e2136-e2147. PubMed ID: 34610990
[TBL] [Abstract][Full Text] [Related]
5. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
[TBL] [Abstract][Full Text] [Related]
6. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.
Krzywicka K; Aguiar de Sousa D; Cordonnier C; Bode FJ; Field TS; Michalski D; Pelz J; Skjelland M; Wiedmann M; Zimmermann J; Wittstock M; Zanotti B; Ciccone A; Bandettini di Poggio M; Borhani-Haghighi A; Chatterton S; Aujayeb A; Devroye A; Dizonno V; Geeraerts T; Giammello F; Günther A; Ichaporia NR; Kleinig T; Kristoffersen ES; Lemmens R; De Maistre E; Mirzaasgari Z; Payen JF; Putaala J; Petruzzellis M; Raposo N; Sadeghi-Hokmabadi E; Schoenenberger S; Umaiorubahan M; Sylaja PN; van de Munckhof A; Sánchez van Kammen M; Lindgren E; Jood K; Scutelnic A; Heldner MR; Poli S; Kruip MJHA; Arauz A; Conforto AB; Aaron S; Middeldorp S; Tatlisumak T; Arnold M; Coutinho JM; Ferro JM;
Eur J Neurol; 2023 May; 30(5):1335-1345. PubMed ID: 36773014
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Sánchez van Kammen M; Aguiar de Sousa D; Poli S; Cordonnier C; Heldner MR; van de Munckhof A; Krzywicka K; van Haaps T; Ciccone A; Middeldorp S; Levi MM; Kremer Hovinga JA; Silvis S; Hiltunen S; Mansour M; Arauz A; Barboza MA; Field TS; Tsivgoulis G; Nagel S; Lindgren E; Tatlisumak T; Jood K; Putaala J; Ferro JM; Arnold M; Coutinho JM; ; Sharma AR; Elkady A; Negro A; Günther A; Gutschalk A; Schönenberger S; Buture A; Murphy S; Paiva Nunes A; Tiede A; Puthuppallil Philip A; Mengel A; Medina A; Hellström Vogel Å; Tawa A; Aujayeb A; Casolla B; Buck B; Zanferrari C; Garcia-Esperon C; Vayne C; Legault C; Pfrepper C; Tracol C; Soriano C; Guisado-Alonso D; Bougon D; Zimatore DS; Michalski D; Blacquiere D; Johansson E; Cuadrado-Godia E; De Maistre E; Carrera E; Vuillier F; Bonneville F; Giammello F; Bode FJ; Zimmerman J; d'Onofrio F; Grillo F; Cotton F; Caparros F; Puy L; Maier F; Gulli G; Frisullo G; Polkinghorne G; Franchineau G; Cangür H; Katzberg H; Sibon I; Baharoglu I; Brar J; Payen JF; Burrow J; Fernandes J; Schouten J; Althaus K; Garambois K; Derex L; Humbertjean L; Lebrato Hernandez L; Kellermair L; Morin Martin M; Petruzzellis M; Cotelli M; Dubois MC; Carvalho M; Wittstock M; Miranda M; Skjelland M; Bandettini di Poggio M; Scholz MJ; Raposo N; Kahnis R; Kruyt N; Huet O; Sharma P; Candelaresi P; Reiner P; Vieira R; Acampora R; Kern R; Leker R; Coutts S; Bal S; Sharma SS; Susen S; Cox T; Geeraerts T; Gattringer T; Bartsch T; Kleinig TJ; Dizonno V; Arslan Y
JAMA Neurol; 2021 Nov; 78(11):1314-1323. PubMed ID: 34581763
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
9. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.
Alhashim A; Hadhiah K; Al Khalifah Z; Alhaddad FM; Al ARhain SA; Bin Saif FH; Abid A; Al Gamdi O; Alsulaiman F; AlQarni M
Am J Case Rep; 2022 Feb; 23():e934744. PubMed ID: 35136010
[TBL] [Abstract][Full Text] [Related]
10. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries.
van de Munckhof A; Borhani-Haghighi A; Aaron S; Krzywicka K; van Kammen MS; Cordonnier C; Kleinig TJ; Field TS; Poli S; Lemmens R; Scutelnic A; Lindgren E; Duan J; Arslan Y; van Gorp EC; Kremer Hovinga JA; Günther A; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; de Sousa DA; Wasay M; Arauz A; Conforto AB; Ferro JM; Coutinho JM;
Int J Stroke; 2023 Oct; 18(9):1112-1120. PubMed ID: 37277922
[TBL] [Abstract][Full Text] [Related]
11. Case Report of Cerebral Sinus Thrombosis Related to Immune Thrombotic Thrombocytopenia Following Administration of ChAdOx1 nCoV-19 for Vaccination against COVID-19.
Szypowski W; Dębiec A; Świstak J; Nowocień M; Rzepecki P; Możański M; Staszewski J; Stępień A
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207456
[TBL] [Abstract][Full Text] [Related]
12. Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis.
Gil-Díaz A; Gil-Hernández A; Lozano-Jiménez AI; Benítez-Peña J; Conde-Martel A
Thromb Res; 2022 Jan; 209():84-85. PubMed ID: 34896915
[TBL] [Abstract][Full Text] [Related]
13. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
[TBL] [Abstract][Full Text] [Related]
14. Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study.
Pelz JO; Kenda M; Alonso A; Etminan N; Wittstock M; Niesen WD; Lambeck J; Güresir E; Wach J; Lampmannn T; Dziewas R; Wiedmann M; Schneider H; Bayas A; Christ M; Mengel A; Poli S; Brämer D; Lindner D; Pfrepper C; Roth C; Salih F; Günther A; Michalski D;
Neurocrit Care; 2024 Apr; 40(2):621-632. PubMed ID: 37498459
[TBL] [Abstract][Full Text] [Related]
15. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
Perry RJ; Tamborska A; Singh B; Craven B; Marigold R; Arthur-Farraj P; Yeo JM; Zhang L; Hassan-Smith G; Jones M; Hutchcroft C; Hobson E; Warcel D; White D; Ferdinand P; Webb A; Solomon T; Scully M; Werring DJ; Roffe C;
Lancet; 2021 Sep; 398(10306):1147-1156. PubMed ID: 34370972
[TBL] [Abstract][Full Text] [Related]
16. Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report.
Di Pietro M; Dono F; Consoli S; Evangelista G; Pozzilli V; Calisi D; Barbone F; Bonanni L; Onofrj M; De Angelis MV; Sensi SL
Neurol Sci; 2022 May; 43(5):2951-2956. PubMed ID: 35217969
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-induced immune thrombotic thrombocytopenia in a male after Ad26.COV2.S vaccination presenting as cerebral venous sinus thrombosis.
Wu JF; Bajwa U; Hammad M
Platelets; 2022 Jul; 33(5):797-800. PubMed ID: 35535430
[TBL] [Abstract][Full Text] [Related]
18. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study.
Shazley O; Alshazley M
Cureus; 2021 Jul; 13(7):e16383. PubMed ID: 34408937
[TBL] [Abstract][Full Text] [Related]
19. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR
JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487
[TBL] [Abstract][Full Text] [Related]
20. Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan.
Ikenberg B; Demleitner AF; Thiele T; Wiestler B; Götze K; Mößmer G; Lingor P
Stroke Vasc Neurol; 2021 Dec; 6(4):668-670. PubMed ID: 34244448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
